Autres langues BetterLife Pharma Inc.

Actions

BETRF

CA08772P2026

Marché Fermé - OTC Markets Autres places de cotation 20:09:36 03/05/2024			Varia. 5j.	Varia. 1 janv.
0,0952 ^USD	+9,47 %		+24,44 %	+98,33 %

01/05	BetterLife Pharma fait progresser les études d'autorisation de mise sur le marché (IND) pour BETR-001	MT
01/05	BetterLife Pharma Inc. fait progresser les études d'autorisation de mise sur le marché de BETR-001	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

BetterLife Announces Intent to Complete Private Placement of Units	00:00
BetterLife Pharma Advances IND-enabling Studies For BETR-001	01/05
BetterLife Advances BETR-001 IND-enabling Studies	01/05
BetterLife Advances BETR-001 IND-enabling Studies	01/05
BetterLife Pharma Inc. Advances BETR-001 IND-Enabling Studies	01/05
BetterLife Pharma Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	15/04
BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	11/04
BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	11/04
BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001	03/04
BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001	03/04
BetterLife Pharma Inc. announced that it has received CAD 1.168 million in funding	03/04
BetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton University	04/03
BetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton University	04/03
BetterLife Pharma Inc. announced that it expects to receive CAD 0.1 million in funding	04/03
BetterLife Pharma Inc. announced that it has received CAD 0.065 million in funding	04/03
BetterLife Closes Convertible Debentures For Further Development of BETR-001	02/01
BetterLife Announces Closing of Convertible Debentures For Further Development of BETR-001	02/01
BetterLife Pharma Inc. announced that it has received CAD 0.3 million in funding	02/01
BetterLife Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	29/12
BetterLife Pharma : MANAGEMENT'S DISCUSSION AND ANALYSIS - Form 6-K	29/12

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues BetterLife Pharma Inc.

Actions

BETRF

CA08772P2026

Autres langues

Filtres